
MOSCOW (Reuters) -A Russian Soyuz MS-28 spacecraft with two Russian cosmonauts and one NASA astronaut on board successfully docked with the International Space Station on Thursday, Russian space agency Roscosmos said.
But the agency later reported that the launch pad at the Baikonur Cosmodrome in Kazakhstan had sustained damage from the launch. It said the damage would be quickly repaired.
The Soyuz 2.1a rocket lifted off from the Baikonur Cosmodrome at 12:28 p.m. Moscow time (0928 GMT).
Late on Thursday, Russian news agencies quoted Roscosmos as saying the launch had taken place without incident, but damage was observed after an inspection of the launch area.
"Damage to a number of elements of the launch pad was detected. An assessment of the state of the launch complex is being conducted now," the agencies quoted Roscosmos as saying.
"All the necessary reserve elements are there to restore it and the damage will be eliminated very soon."
It said the crew was on board the station and in good health.
(Reporting by Anastasia Lyrchikova; Writing by Marina Bobrova; Editing by Andrew Osborn, Ron Popeski and Bill Berkrot)
LATEST POSTS
- 1
Is an $85 apple pie worth it? Our Thanksgiving taste test says … maybe. - 2
I took my shoes off and went for a barefoot hike. I couldn’t believe what happened next - 3
Experience Unrivaled Sound: Top Speakers You Really want to Hear - 4
IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports - 5
As reefs vanish, assisted coral fertilization offers hope in the Dominican Republic
Blue Origin launches New Glenn rocket on company's first NASA-scale science mission
Dozens killed as Angola flood death toll rises
Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
Remarkable Spots for Hot Air Swelling All over The Planet
A Manual for Extravagant Vehicles Available in 2024
5 Instructive Toy Brands for Youngsters
Where America’s CO2 emissions come from – what you need to know, in charts
Figure out How to Clean and Really focus on Your Lab Jewel
Novo Nordisk slashes prices of popular weight loss and diabetes drugs













